Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
PLoS One ; 18(3): e0282302, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36857371

RESUMEN

OBJECTIVES: This study aimed to compare profiles of coping among females with thyroid disorders and females from a healthy control group regarding depression levels and body image anxiety. We also wanted to check whether subjectively experienced Covid-19-related psychological distress moderated the above-mentioned association in both groups of participants. METHOD: The study sample comprised 564 females, of which 329 were diagnosed with a thyroid disease and 235 formed the healthy control group. Participants filled out paper-and-pencil or online versions of psychometric questionnaires to assess coping strategies, depression, and body image anxiety. RESULTS: In general, we observed higher depression intensity and a higher level of body image anxiety among females with thyroid diseases than among the healthy control group. Latent profile analysis revealed adaptive vs. maladaptive coping profiles from both study samples. Depression symptoms were significantly higher if coping was maladaptive in both the clinical and control groups. Still, there were no significant differences in body image anxiety between participants with adaptive and maladaptive coping profiles. Covid-19-related distress did not moderate the link between coping profiles, depression, and body image anxiety in either group. CONCLUSION: Greater focus should be placed on the role of body image in females struggling with thyroid diseases. Bodily therapy may help these patients to cope better with co-occurring thyroid diseases and mental disorders, whose relationship is still not fully understood.


Asunto(s)
COVID-19 , Enfermedades de la Tiroides , Humanos , Femenino , Imagen Corporal , Depresión , Pandemias , Ansiedad , Adaptación Psicológica
2.
Int J Mol Sci ; 22(4)2021 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-33671616

RESUMEN

Sexually transmitted infections (STIs) caused by Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium are a common cause of pelvic inflammatory disease (PID) which can lead to tubal factor infertility (TFI). TFI is one of the most common causes of infertility, accounting for 30% of female fertility problems. STIs can also have an impact on pregnancy, leading to adverse pregnancy outcomes. Escalating antibiotic resistance in Neisseria gonorrhoeae and Mycoplasma genitalium represents a significant problem and can be therapeutically challenging. We present a comprehensive review of the current treatment options, as well as the molecular approach to this subject. We have given special attention to molecular epidemiology, molecular diagnostics, current and new treatments, and drug resistance.


Asunto(s)
Farmacorresistencia Bacteriana/efectos de los fármacos , Infertilidad Femenina/microbiología , Complicaciones Infecciosas del Embarazo/etiología , Enfermedades Bacterianas de Transmisión Sexual/complicaciones , Enfermedades Bacterianas de Transmisión Sexual/tratamiento farmacológico , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Infecciones por Chlamydia/tratamiento farmacológico , Infecciones por Chlamydia/etiología , Infecciones por Chlamydia/microbiología , Trompas Uterinas/microbiología , Trompas Uterinas/patología , Femenino , Gonorrea/tratamiento farmacológico , Gonorrea/etiología , Humanos , Técnicas de Diagnóstico Molecular , Epidemiología Molecular/métodos , Infecciones por Mycoplasma/tratamiento farmacológico , Infecciones por Mycoplasma/etiología , Mycoplasma genitalium/patogenicidad , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/epidemiología , Enfermedades Bacterianas de Transmisión Sexual/diagnóstico , Enfermedades Bacterianas de Transmisión Sexual/epidemiología
3.
Artículo en Inglés | MEDLINE | ID: mdl-33440750

RESUMEN

HPV (human papillomavirus) vaccinations have been introduced into the population of many countries through vaccination programs, although their acceptance varies from country to country, largely dependent on the state of knowledge about diseases caused by genital HPV types as well as cultural, social, and religious factors. The aim of the study was to analyze the state of knowledge about HPV and HPV vaccines among doctors during their specialization in gynecology and obstetrics, dermatology and venereology, and pediatrics. Another objective of the study was to analyze the impact of the state of knowledge about HPV vaccination on their attitude to primary prevention, i.e., vaccinations. A questionnaire was used to collect the data and 639 doctors took part in the study. The analysis was carried out mainly using descriptive statistical methods. In Poland, doctors' knowledge about HPV is low, independent of gender, age, and subject of specialization. Doctors' knowledge about the HPV vaccine is very low and independent of sex, age, and subject of specialization. However, doctors' knowledge about HPV and the HPV vaccine influences the attitude to HPV vaccination and does not affect pro-active behaviors.


Asunto(s)
Infecciones por Papillomavirus , Vacunas contra Papillomavirus , Neoplasias del Cuello Uterino , Niño , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Infecciones por Papillomavirus/prevención & control , Aceptación de la Atención de Salud , Polonia , Encuestas y Cuestionarios , Neoplasias del Cuello Uterino/prevención & control , Vacunación
4.
Prz Menopauzalny ; 19(4): 195-199, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33488333

RESUMEN

During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep. The symptoms of vulvovaginal atrophy are especially troublesome for menopausal women. These symptoms not only disturb the sexual sphere, but also functioning at work and in the family. Based on the literature, a review of contemporary methods of management in the case of symptoms of vulvar atrophy in menopausal women has been performed. The current methods of treating vulvovaginal atrophy in menopausal women are described. The pharmacology of the available dehydroepiandrosterone (DHEA) preparations, both oral and vaginal, was briefly analyzed. Own experiences of using DHEA are presented. Vaginal DHEA has been found to be an effective and safe treatment in menopausal women with symptoms of vaginal atrophy.

5.
Prz Menopauzalny ; 17(3): 105-108, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30357004

RESUMEN

Premature ovarian insufficiency (POI) is defined as a cessation of ovarian function before the age of 40 years. It is associated with hypoestrogenism and loss of residual follicles, both of which lead to menstrual abnormalities, pregnancy failures, and decreased health-related quality of life. The prevalence of POI is estimated at 1% in the general population. Current European Society of Human Reproduction and Embryology (ESHRE) diagnostic criteria include: amenorrhoea or oligomenorrhoea for at least four months and increased follicle-stimulating hormone (FSH) levels > 25 IU/l measured twice (with a four-week interval). The aetiopathogenesis of the disease in most cases remains unexplained. Nevertheless, in some patients with POI, genetic abnormalities, metabolic disorders, autoimmunity, iatrogenic procedures, infections, or environmental factors have been established as underlying causes of the syndrome.

6.
Prz Menopauzalny ; 17(3): 131-134, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30357024

RESUMEN

Premature ovarian insufficiency (POI) occurs in 1% of women under 40 years old. Hypoestrogenism associated with this condition may result in vaginal atrophy and urine incontinence, called genitourinary syndrome. The symptoms include: vaginal dryness, irritation, dyspareunia, and dysuria. There is relative lack of studies on the occurrence and treatment of genitourinary problems in women with POI. Prevalence rates vary from 17 to 54% depending on cause, duration of oestrogen depletion, and the treatment used. Patients with POI gain lower scores in tests measuring vaginal health or sexual function in comparison to healthy peers. Hormonal treatment in premature ovarian insufficiency is recommended until the natural age of menopause. The vaginal route of oestrogen administration is supposed to be the criterion standard in treating genitourinary symptoms. Androgen supplementation is not routinely recommended.

7.
Prz Menopauzalny ; 17(3): 135-138, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30357030

RESUMEN

Premature ovarian insufficiency (POI) correlates with increased risk of cardiovascular diseases, osteoporosis, genitourinary syndrome, and other symptoms of prolonged oestrogen deprivation. Properly selected therapy improves the quality of women's lives and reduces the risk of mortality. There is a wide spectrum of available oestrogen and progestogen formulations restoring proper levels of serum sex steroid hormones. The treatment should be implemented at recognition of the POI and continued to at least the age of natural menopause. Transdermal oestradiol and oral or vaginal progesterone administration provide the most physiological sex steroid replacement therapy. Patients' views and individual preference according the route, dose, and regimen of hormonal treatment have to be taken into consideration in order to achieve high compliance rates. Women with POI should be managed by a multidisciplinary team, such as a gynaecologist, endocrinologist, dietitian, and psychologist.

8.
Ginekol Pol ; 80(7): 503-7, 2009 Jul.
Artículo en Polaco | MEDLINE | ID: mdl-19697813

RESUMEN

OBJECTIVE: Aim of the study was to assess the usefulness of ultrasound endometrial thickness measurement in the diagnosis of endometrial pathology in women with abnormal peri- and postmenopausal bleeding. MATERIAL AND METHODS: Material included 182 patients whose endometrium sample was obtained for analysis. Patients were divided into six groups according to histological findings. RESULTS: Correlation between thickness of endometrium and histological diagnostic was sought. Wide and partially covered range of endometrium thickness were found in the observed groups. In carcinoma group the highest were maximal and average values. The difference in average thickness of endometrium in carcinoma and hyperplasia groups when compared to the remaining groups proved to be statistically significant A value of cut down ultrasound measured endometrial thickness to exclude endometrial cancer was 9 mm. CONCLUSION: Ultrasound measurement of endometrial thickness is not sufficient to increase effectiveness of endometrial pathology diagnosis in women with abnormal peri- and postmenopausal bleeding.


Asunto(s)
Hiperplasia Endometrial/diagnóstico por imagen , Neoplasias Endometriales/ultraestructura , Endometrio/diagnóstico por imagen , Endometrio/patología , Hemorragia Uterina/diagnóstico por imagen , Adulto , Anciano , Hiperplasia Endometrial/complicaciones , Hiperplasia Endometrial/patología , Neoplasias Endometriales/complicaciones , Neoplasias Endometriales/patología , Femenino , Humanos , Persona de Mediana Edad , Perimenopausia , Posmenopausia , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Ultrasonografía , Hemorragia Uterina/etiología
9.
Med Pr ; 55(5): 439-43, 2004.
Artículo en Polaco | MEDLINE | ID: mdl-15768898

RESUMEN

The aim of the work was to review the current literature on the sacral-lumbar spine pains and on the factors that might be responsible for their incidence. The authors present the selection of therapeutic methods and the evaluation of their efficacy with special reference to sickness absence from work.


Asunto(s)
Dolor de la Región Lumbar/etiología , Dolor de la Región Lumbar/rehabilitación , Ausencia por Enfermedad/economía , Humanos , Incidencia , Dolor de la Región Lumbar/economía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...